Banks Jerel A. 4
4 · Benitec Biopharma Inc. · Filed Dec 11, 2020
Insider Transaction Report
Form 4
Banks Jerel A.
DirectorChief Executive Officer
Transactions
- Award
Options (right to buy)
2020-12-09+284,345→ 284,345 totalExercise: $2.98Exp: 2030-12-09→ Common Stock (284,345 underlying)
Footnotes (1)
- [F1]The stock options will vest in three substantially equal installments on December 9, 2021, December 9, 2022, and December 9, 2023.